- with
Merck KGaA in 2014. In
January 2016 Juno
announced it had
acquired AbVitro,
allowing it to use next-generation
single cell
sequencing platforms to...
- In
vitro fertilisation (IVF) is a
process of
fertilisation in
which an egg is
combined with
sperm in
vitro ("in gl****"). The
process involves monitoring...
-
collaboration with the
Satija lab.,
while a
similar approach was
earlier shown by
AbVitro Inc..
Concurrent measurement of both
protein and
transcript levels opens...
-
Pathogenica (microbe and
viral NGS diagnostics, 2009, with Yemi Adesokan),
AbVitro (immunomes, 2010, with
Francois Vigneault), Gen9 Bio (synthetic biology...
- (Acq 2017)
Impact Biomedicines (Acq 2018) Juno
Therapeutics (Acq 2018)
AbVitro (Acq 2016)
RedoxTherapies (Acq 2016) In
March 2016, Bob Hugin, the company's...
- (Acq 2017)
Impact Biomedicines (Acq 2018) Juno
Therapeutics (Acq 2018)
AbVitro (Acq 2016)
RedoxTherapies (Acq 2016)
Forbius (Acq 2020)
MyoKardia (Acq...
- In
vitro compartmentalization (IVC) is an emulsion-based
technology that
generates cell-like
compartments in
vitro.
These compartments are
designed such...
- A
monoclonal antibody (m
Ab, more
rarely called mo
Ab) is an
antibody produced from a cell
lineage made by
cloning a
unique white blood cell. All subsequent...
-
AB-CHMINACA is an indazole-based
synthetic cannabinoid. It is a
potent agonist of the CB1
receptor (Ki = 0.78 nM) and CB2
receptor (Ki = 0.45 nM) and fully...
-
January 2006.[citation needed] The
first steps towards the
present Phadia AB were
taken in the mid 1960s.
Three scientists working at
Uppsala University...
